PRLR and breast carcinoma: To further evaluate the clinical value of PRLR co-expression with TGFβ receptors in breast cancer, the correlation of the expression of the three receptors was examined in relation to patient survival outcomes using distant metastasis-free survival (DMFS) as an endpoint in the GOBO database.